Table 1 Results of multivariable analysis for associations between pretherapy clinical factors and positive treatment response (≥ 50% reduction in monthly headache days) rate in migraine patients.

From: Changes in interictal cerebral blood flow observed in migraine patients who respond to anti-calcitonin gene-related peptide therapy

Predictive factors

Odds ratio

95%CI

p value

Clinical factors

   

 BDI-II score < 11

8.500

1.788–40.420

0.007

Neuroradiological factors

   

 No CHP findings with insomnia

9.502

1.897–47.600

0.006

 No insomnia with WMHs

6.187

1.533–24.971

0.010

  1. CI, confidence interval; BDI-II, Beck depression inventory, second edition; CHP, cortical hyperperfusion on magnetic resonance imaging-arterial spin labeling; WMHs, white matter hyperintensities.
  2. Significance values are in bold.
Back to article page